>

WuXi AppTec to Showcase Scientific Expertise at AACR 2021 - Join us!

WuXi AppTec is excited to showcase our scientific expertise during this year's AACR Annual Meeting, April 10-15, 2021. The AACR Annual Meeting covers the latest discoveries across the full spectrum of cancer research, highlighting the work of the best minds in research and medicine from institutions all over the world.

Attend our poster presentations, and visit our virtual exhibition to get your urgent oncology drug discovery questions answered by our experienced scientists. Pre-arrange your one-on-one meeting with our team here or email Wendy Liu directly at wendy_liu@wuxiapptec.com.

ePoster Presentations

Title	Session Category	Abstract Number	E-poster Presentation	Presenter/Author
Myeloid-dominated spontaneous tumor models as the tool for the evaluation of immune modulators	Immunology	1654	April 10 (8:30am- 11:59pm)	Xuzhen Tang
Tumor evolution selectively inactivates microRNA machinery for immune evasion	Tumor Biology	3140	April 10 (8:30am- 11:59pm)	Haixin Zhao
Establishment of KRAS-G12C inhibitor induced resistant tumor models enable the development of new generation KRAS-G12C inhibitors and combinatorial strategies	Tumor Biology	2959	April 10 (8:30am- 11:59pm)	Gaoxiang Liu
Establishment and Optimization of scRNASeq assay to find the mechanism of immune therapy against tumors	Tumor Biology	2721	April 10 (8:30am- 11:59pm)	Qiyao Zhang
Engineered cell line panel complemented with in vivo models to enable next-generation target therapy discovery in cancer	Experimental and Molecular Therapeutics	1118	April 10 (8:30am- 11:59pm)	Zhixiang Zhang
Establishment of KRAS G12C mutant patient-derived xenograft (PDX) models for pre-clinical evaluation of KRAS G12C targeted anticancer therapy	Tumor Biology	3004	April 10 (8:30am- 11:59pm)	Wenting Shi
Establishment of in vitro human T cell exhaustion model to enable high throughput target validation for T cell phenotype restoring	Tumor Biology	2774	April 10 (8:30am- 11:59pm)	Tienan Wang
Siglec-15 knockout inhibits tumor growth in mouse model	Immunology	1634	April 10 (8:30am- 11:59pm)	Peixue Li
Identification of Tofacitinib, Filgotinib and Ruxolitinib on experimental Sjögren’s syndrome model in mice	Experimental and Molecular Therapeutics	1036	April 10 (8:30am- 11:59pm)	Ruiqing Yan
Validation of GVHD in humanized mouse model for preclinical efficacy screen	Immunology	1694	April 10 (8:30am- 11:59pm)	Yingying Cai
Cancer driver screens identify regulators of immune checkpoint blockade therapy response	Immunology	1600	April 10 (8:30am- 11:59pm)	Wenrong Zhou
Drug induced resistant tumor models enable the development of next-generation anticancer therapeutics	Tumor Biology	2958	April 10 (8:30am- 11:59pm)	Ting Ni

Download our oncology literature here:

Oncology Services Introduction Brochure

Immuno-Oncology Platform

CRISPR/CAS9 Gene Editing